Protagenic Therapeutics Inc [NASDAQ: PTIX] gained 266.34% or 8.07 points to close at $11.10 with a heavy trading volume of 97013392 shares.
The daily chart for PTIX points out that the company has recorded 21.98% gains over the past six months.
If we look at the average trading volume of 446.99K shares, PTIX reached to a volume of 97013392 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Trading performance analysis for PTIX stock
Protagenic Therapeutics Inc [PTIX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 262.75. With this latest performance, PTIX shares gained by 230.49% in over the last four-week period, additionally plugging by 21.98% over the last 6 months – not to mention a drop of -36.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PTIX stock in for the last two-week period is set at 83.49, with the RSI for the last a single of trading hit 89.12, and the three-weeks RSI is set at 77.97 for Protagenic Therapeutics Inc [PTIX]. The present Moving Average for the last 50 days of trading for this stock 3.70, while it was recorded at 4.81 for the last single week of trading, and 6.70 for the last 200 days.
Protagenic Therapeutics Inc [PTIX]: A deeper dive into fundamental analysis
Protagenic Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.86 and a Current Ratio set at 0.86.
